v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Income (Loss) $ (67,574) $ (92,967)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 6,605 4,311
Net accretion of discounts on marketable securities (6,847) (10,396)
Amortization of debt issuance costs 945 953
Amortization of deferred contract acquisition costs 13,931 12,762
Non-cash operating lease costs 1,075 885
Stock-based compensation, net of amounts capitalized 92,575 95,322
Deferred income taxes (17,338) 615
Other 454 849
Changes in operating assets and liabilities, net of effects of business combinations:    
Accounts receivable 15,414 29,360
Deferred contract acquisition costs (10,410) (9,732)
Prepaid expenses and other assets 1,515 (1,929)
Accounts payable (1,274) (4,932)
Accrued expenses and other liabilities (49,828) (43,752)
Operating lease liabilities (2,177) (1,935)
Deferred revenue (3,820) (5,368)
Net cash used in operating activities (26,754) (25,954)
CASH FLOWS FROM INVESTING ACTIVITIES    
Capitalization of internal-use software costs (4,806) (5,539)
Purchases of marketable securities (405,235) (443,307)
Maturities of marketable securities 299,467 432,267
Purchases of property and equipment (1,429) (186)
Net cash used in investing activities (112,003) (16,765)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from issuance of common stock upon exercise of vested options 16,606 14,401
Proceeds from issuance of common stock under employee stock purchase plan 14,195 15,603
Net cash provided by financing activities 30,801 30,004
Effect of exchange rate changes on cash and cash equivalents 537 (673)
Net decrease in cash and cash equivalents (107,419) (13,388)
Cash and cash equivalents at beginning of period 385,980 349,761
Cash and cash equivalents at end of period 278,561 336,373
Cash paid for:    
Income taxes 2,328 1,814
Non-cash investing and financing activities:    
Stock-based compensation capitalized as internal-use software costs 3,342 5,597
Vesting of early exercised stock options $ 126 $ 316